Skip to main content

Vaporised nicotine products for smoking cessation

Hunter New England Local Health District

  • Translational Research Grants Scheme
Date Funded:
  • 13 June, 2019
Chief Investigator/s:
  • Professor Adrian Dunlop

Tobacco smoking causes cardiovascular disease, cancer, chronic respiratory disease and a multitude of other negative outcomes. Tobacco smoking rates are highest among people on opiate agonist treatment (OAT), and they find it difficult to quit smoking, even when they are interested and motivated to quit.

This study is testing whether NRT and vaporised nicotine products, such as e-cigarettes, help OAT clients to quit their tobacco smoking. If found to be effective, e-cigarettes can be used with health care provider and telephone Quitline support, to help people in opiate treatment services to quit smoking tobacco cigarettes.

This type of support can be rolled out across all drug and alcohol services in NSW, profoundly improving OAT clients, physical health, mental health, financial position and quality of life.